Recommended for you

Swedish cancer experts weigh in and stress that quitting smoking remains the best way to reduce lung cancer risk.

Your one-stop shop for some of the latest health news featuring Swedish experts.

Groundbreaking research designed to assess the effectiveness of CAR-T cell therapy on lupus and multiple sclerosis is in the early stages at Swedish.

Michael Chiorean, M.D., co-director of the IBD Center at Swedish, was an investigator in the study that helped win approval for the new medication.

The initiative, a joint venture with the Washington State Hospital Association and others, seeks to ensure shared decision-making processes between birthing parents and clinicians.

The Jada System provides immediate intervention for the dangerous condition, allowing more bonding time for birthing parent and baby.

Seattle’s KING 5 TV hosted a panel of sought-after Swedish specialists for a conversation about advanced treatments at Swedish and why patients from around the world choose us for their care.

The gold award from the Extracorporeal Life Support Association is among the international organization’s highest honors.

With a groundbreaking program at Swedish, first-year residents are leading change in their field.

Swedish offers revolutionary heart care for tricuspid regurgitation. Our experts share treatment options and explain why the new procedure offers new hope.

Swedish’s MS Center is the most comprehensive and among the largest in the United States.

As part of an international data-sharing consortium of leading cancer centers, Swedish Cancer Institute and Providence Cancer Institute work together to provide genomic data to Project GENIE.

Heart specialists at Swedish recently completed their 500th MitraClip™ procedure for patients with leaky hearts. Learn more about what that means for heart care.

Swedish First Hill medical director for robotic surgery received this year's Menon Award at the North American Robotic Urology Symposium.

Review information about cancer prevention shared by experts at the Swedish Cancer Institute in this collection of past blog posts.

Swedish recently hit the 100-patient milestone for Cellular therapy. Learn what the accomplishment means for cancer patients in the region.

Findings show that most organs from COVID-positive donors can be used with excellent short-term outcomes.

Swedish’s program has received certification from DNV, a national healthcare certification and accreditation organization.

New technology provides a highly personalized approach to radiation treatments for patients with cancer.

A patient with advanced skin cancer shares how innovative treatment at Swedish Cancer Institute helped him beat the odds.